Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice

References

1. Allan W., Taga T., Cleary A., Doherty P. C. 1990; Cellular events in the lymph node and lung of mice with influenza. Journal of Immunology 144:3980–3986
   [Google Scholar]
2. Blaskovic D., Stancekova J., Svobodova J., Mistrikova J. 1980; Isolation of five strains of herpesviruses from two species of freeliving small rodents. Acta Virologica 24:468
   [Google Scholar]
3. Chen F., Zou J. Z., Direnzo L., Winberg G., Hou L. F., Klein E., Klein G., Ernberg I. 1995; A subpopulation of latently EBV-infected normal B cells resemble Burkitt lymphoma (BL) cells in expressing EBNA 1 but not ENBA 2 or LMP1. Journal of Virology 69:3752–3758
   [Google Scholar]
4. Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. 1984; Therapy with monoclonal antibodies: elimination of T cell subsets in vivo . Nature 312:548–551
   [Google Scholar]
5. Constant S., Schweitzer N., West J., Ranney P., Bottomley K. 1995; B lymphocytes can be competent antigen-presenting cells for priming T cells to protein antigens in vivo . Journal of Immunology 155:3734–3741
   [Google Scholar]
6. Efstathiou S., Ho Y. M., Minson A. C. 1990a; Cloning and molecular characterization of the murine herpesvirus 68 genome. Journal of General Virology 71:1355–1364
   [Google Scholar]
7. Efstathiou S., Ho Y. M., Hall S., Styles C. J., Scott S. D., Gompels U. A. 1990b; Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein–Barr virus and herpesvirus saimiri. Journal of General Virology 71:1365–1372
   [Google Scholar]
8. Egan J. J., Stewart J. P., Hasleton P. S., Arrand J. R., Carroll K. B., Woodcock A. 1995; Epstein–Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosising alveolitis. Thorax 50:1234–1239
   [Google Scholar]
9. Ehtisham S., Sunil-Chandra N. P., Nash A. A. 1993; Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. Journal of Virology 67:5247–5252
   [Google Scholar]
10. Epstein M. M., Dirosa F., Jankovic D., Sher A., Matzinger P. 1995; Successful T cell priming in B cell-deficient mice. Journal of Experimental Medicine 182:915–922
    [Google Scholar]
11. Henle G., Henle W. 1976; Epstein–Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. International Journal of Cancer 17:1–7
    [Google Scholar]
12. Henle W., Henle G. 1979; Seroepidemiology of the virus. In The Epstein–Barr Virus pp 61–78 Edited by Epstein M. A., Achong B. G. Berlin: Springer-Verlag;
    [Google Scholar]
13. Kaegi D., Ledermann B., Buerki K., Seiler P., Odermatt B., Olsen K. J., Podack E. R., Zinkernagel R. M., Hengartner H. 1994; Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31–37
    [Google Scholar]
14. Kitamura D., Roes J., Kuhn R., Rajewsky K. 1991; A B cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin y chain gene. Nature 350:423–426
    [Google Scholar]
15. Lung M. L., Lam W. K., So S. Y., Lam W. P., Chan K. H., Ng K. H. 1985; Evidence that respiratory tract is a major reservoir for Epstein–Barr virus. Lancet i:889–892
    [Google Scholar]
16. Miyashita E., Yang B., Lam K. M. C., Crawford D. H., ThorleyLawson D. A. 1995; A novel form of Epstein–Barr virus latency in normal B cells in vivo . Cell 80:593–601
    [Google Scholar]
17. Nash A. A., Usherwood E. J., Stewart J. P. 1996; Immunological features of murine gammaherpesvirus infection. Seminars in Virology 7:125–130
    [Google Scholar]
18. Qu L., Rowe D. T. 1992; Epstein–Barr virus latent gene expression in uncultured peripheral blood lymphocytes. Journal of Virology 66:3715–3724
    [Google Scholar]
19. Sarawar S., Cardin R. D., Brooks J. W., Mehrpooya M., Tripp R. A., Doherty P. C. 1996; Cytokine production in the immune response to murine gammaherpesvirus-68. Journal of Virology 70:3264–3268
    [Google Scholar]
20. Stewart J. P., Janjua N. J., Pepper S. V., Bennion G., Mackett M., Allen T., Nash A. A., Arrand J. R. 1996; Identification and characterization of murine gammaherpesvirus 68 gpl50: a virion membrane glycoprotein. Journal of Virology 70:3528–3535
    [Google Scholar]
21. Sunil-Chandra N. P., Efstathiou S., Nash A. A. 1992a; Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo . Journal of General Virology 73:3275–3279
    [Google Scholar]
22. Sunil-Chandra N. P., Efstathiou S., Arno J., Nash A. A. 1992b; Virological and pathological features of mice infected with murine gammaherpesvirus 68. Journal of General Virology 73:2347–2356
    [Google Scholar]
23. Sunil-Chandra N. P., Efstathiou S., Nash A. A. 1993; Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology 193:825–833
    [Google Scholar]
24. Sunil-Chandra N. P., Arno J., Fazakerley J., Nash A. A. 1994; Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. American Journal of Pathology 145:818–826
    [Google Scholar]
25. Tierney R. J., Steven N., Young L. S., Rickinson A. B. 1994; Epstein–Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. Journal of Virology 68:7374–7385
    [Google Scholar]
26. Usherwood E. J., Ross A. J., Allen D. J., Nash A. A. 1996a; Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. Journal of General Virology 77:627–630
    [Google Scholar]
27. Usherwood E. J., Stewart J. P., Nash A. A. 1996b; Characterization of tumor cell lines derived from murine gammaherpesvirus 68-infected mice. Journal of Virology 70:6516–6518
    [Google Scholar]
28. Xie W., Pinto C. E., Kradin R. L. 1995; The antigen-presenting activities of Ia-+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. Journal of Experimental Medicine 181:1275–1283
    [Google Scholar]